Aclaris Therapeutics, Inc.
Aclaris Therapeutics develops small-molecule and biologic product candidates for immuno-inflammatory diseases.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story
November 2026
October 2026
August 2026
Aclaris Therapeutics develops small-molecule and biologic product candidates for immuno-inflammatory diseases.
November 2026
October 2026
August 2026